
Consensus GWAS uncovers 91 ADRD risk loci and ties polygenic risk to Alzheimer’s pathology
A European-ancestry meta-analysis of ADRD GWAS (128,681 cases/proxy; 849,833 controls) identified 91 genome-wide loci, including 16 new ones, with 56 loci influencing clinically diagnosed Alzheimer’s disease (18 tier-2 loci needing external validation). Excluding APOE, polygenic scores were linked to AD pathology: in top-decile individuals, Braak stage >4 and moderate/severe neuritic plaques at death were about 2× more likely, though overall predictive power is modest (roughly 4% of variance explained; small AUC gains). Results held across main, no-proxy, and no-biobank analyses and showed microglia enrichment and pathways tied to tau, amyloid, lipids, and immunity; genetic correlations connected ADRD with Lewy body dementia, ALS, PD and educational attainment. The authors call for larger well-characterized neuropathology datasets to clarify locus effects on AD pathology versus other dementias and provide further external validation for certain loci and no-proxy/no-biobank statistics for broader use.

